WT-1 Antibody (Immunohistochemistry)

The WT-1 (Wilms Tumor 1) Antibody is an important IHC marker. It helps identify
mesothelial, ovarian, renal, and several sarcomatous tumors.
In addition, WT-1 is a 52–54 kDa nuclear transcription factor involved in the development and survival
of mesodermal and epithelial cells.

Moreover, WT-1 expression appears in mesothelial cells, ovarian serous carcinomas, fetal kidneys,
and some sarcomatoid tumors. As a result, it becomes a key marker for distinguishing
malignant mesothelioma from metastatic adenocarcinoma.
Therefore, WT-1 plays a central role in diagnostic pathology.

🔬 Features and Benefits

• Specific marker for mesothelial and ovarian tumors
• Clear brown nuclear staining in positive cells
• Valuable for diagnosing Wilms tumor and differentiating mesothelioma
• Compatible with routine IHC diagnostic protocols
• Stable for up to 18 months at 2–8 °C

💡 Diagnostic Applications

• Diagnosis of malignant mesothelioma
• Detection of ovarian serous carcinoma and Wilms tumor
• Differentiation between mesothelioma and metastatic adenocarcinoma
• Research on embryonic and developmental tumor pathways

🌐 Fardad Azma Rad Co.

Fardad Azma Rad Co., the exclusive representative of
Talent Biomedical i in Iran, provides high-quality IHC antibodies such as WT-1.
Furthermore, the company focuses on diagnostic precision, scientific reliability, and global standards.
As a result, pathology laboratories across Iran benefit from consistent and advanced solutions.

“Download Brochure”